Myomo (MYO) EBIT (2016 - 2025)

Myomo has reported EBIT for 10 years, with the latest figure at -$3.5 million in Q3 2025.

• For the quarter ending Q3 2025, EBIT fell 267.34% year-over-year to -$3.5 million; the trailing twelve-month figure through Sep 2025 stood at -$11.9 million (down 41.44% YoY), and the FY2024 full-year result was -$6.2 million, up 24.6% from the prior year.
• EBIT for Q3 2025 stood at -$3.5 million, up from -$4.6 million in the prior quarter.
• The five-year high for EBIT was -$245314.0 in Q4 2024, with the low at -$4.6 million in Q2 2025.
• Historically, EBIT has averaged -$2.5 million across 5 years, with a median of -$2.7 million in 2023.
• Annual changes were most pronounced in 2024 — EBIT surged 89.92% — and 2025, when it slumped 311.66%.
• Myomo's EBIT stood at -$2.7 million in 2021, then increased by 17.61% to -$2.2 million in 2022, then declined by 9.14% to -$2.4 million in 2023, then surged by 89.92% to -$245314.0 in 2024, then plunged by 1333.88% to -$3.5 million in 2025.
• The last three EBIT figures came in at -$3.5 million (Q3 2025), -$4.6 million (Q2 2025), and -$3.5 million (Q1 2025), per Business Quant data.